NEFL and myeloid sarcoma: Additionally, studies have demonstrated that increased blood levels of NF-L in the early stages of MS may predict future increases in MS lesions and brain atrophy (Williams et al., 2021; Chitnis et al., 2018; Novakova et al., 2017; Håkansson et al., 2017).